1. Alveolar bone loss in liver transplantation patients: relationship with prolonged steroid treatment and parathyroid hormone levels
- Author
-
Sofia Ish-Shalom, Shlomi Barak, Yaacov Baruch, Elena Segal, Orit Oettinger-Barak, and Eli E. Machtei
- Subjects
Adult ,Male ,medicine.medical_specialty ,Time Factors ,medicine.medical_treatment ,Alveolar Bone Loss ,Parathyroid hormone ,Peptide hormone ,Liver transplantation ,vitamin D deficiency ,Bone Density ,Internal medicine ,Alveolar Process ,medicine ,Vitamin D and neurology ,Humans ,Mandibular Diseases ,Aged ,business.industry ,Age Factors ,Middle Aged ,medicine.disease ,Maxillary Diseases ,Liver Transplantation ,Radiography ,Osteopenia ,Cross-Sectional Studies ,Endocrinology ,Parathyroid Hormone ,Regression Analysis ,Periodontics ,Female ,Steroids ,Secondary hyperparathyroidism ,business ,Immunosuppressive Agents ,Hormone - Abstract
Aim: To evaluate the relationship among alveolar bone loss (ABL), bone status and calcium-regulating hormones in liver transplantees. Patients and Methods: Twenty-one liver transplantees underwent a full oral examination. The correlations among bone densitometry, bone metabolic status and drug treatment were examined. Results: Twelve patients had osteopenia, and six were osteoporotic. ABL was 4.33±2.32 mm (range 0.67–9.92). Parathyroid hormone (PTH) levels ranged from 14 to 106 (mean 55.2±26.4). The mean 25(OH)D3 was 11.68±4.7, range 3.5–21.1 ng/ml. Nine patients were vitamin D deficient ( more...
- Published
- 2007
- Full Text
- View/download PDF